PDE4A and Alzheimer disease: Out of the 68 topical AD treatments ranging from TCS, wet wrap therapy, topical calcineurin inhibitors (TCI), PDE4 inhibitors, JAK inhibitors, etc., the study found that group 5 TCS which are lower to medium potency TCS was the most effective, improving 6/7 factors with “moderate-to-high certainty of evidence”